• Home  
  • Health Equity & Access Weekly Roundup: November 20, 2026
Health Equity & Access Weekly Roundup: November 20, 2026
- Health

Health Equity & Access Weekly Roundup: November 20, 2026

Low CRC Incidence Found After Endoscopic Mucosal Resection A study in the Journal of Gastrointestinal Cancer used the TriNetX US Collaborative Network to follow 3081 patients who underwent endoscopic mucosal resection (EMR) between 2016 and 2017. Over 10,187.8 person-years, 22 patients received a colorectal cancer (CRC) diagnosis, an incidence of 2.16 per 1000 person-years (95%

Low CRC Incidence Found After Endoscopic Mucosal Resection

A study in the Journal of Gastrointestinal Cancer used the TriNetX US Collaborative Network to follow 3081 patients who underwent endoscopic mucosal resection (EMR) between 2016 and 2017. Over 10,187.8 person-years, 22 patients received a colorectal cancer (CRC) diagnosis, an incidence of 2.16 per 1000 person-years (95% CI, 1.35-3.27), and an analysis limited to patients aged 50 to 75 years produced a nearly identical estimate. The point estimate was higher among Black, Asian, and unknown-race patients combined than among White patients (3.16 vs 1.94 per 1000 person-years), but it rested on only 7 events, and CIs overlapped. The authors said missing data on surveillance adherence and insurance continuity limited conclusions about equitable surveillance.

Urban Hospital Care Linked to Better HFrEF Outcomes for Rural Patients

A JAMA Cardiology study of 735,460 Medicare fee-for-service beneficiaries hospitalized for heart failure with reduced ejection fraction (HFrEF) from 2013 to 2021 examined how patient and hospital rurality shape care. Rural patients treated at urban hospitals had about twice the odds of an inpatient cardiology consultation (OR, 2.02; 95% CI, 1.84-2.22) and lower 90-day mortality (OR, 0.94; 95% CI, 0.91-0.97) than rural patients treated at rural hospitals. Even so, they had higher 30-day mortality (OR, 1.10; 95% CI, 1.06-1.14) than urban patients treated at the same hospitals, with no significant difference at 1 year. The authors cited delayed follow-up, social determinants of health, and medication affordability as possible contributors and pointed to transitional care and telehealth follow-up.

GLP-1s Alone Won’t Solve Obesity, JAMA Summit Report Says

A report from the JAMA Summit on Obesity, published in JAMA, concluded that effective obesity medications offer a major opportunity but cannot reverse an epidemic rooted in structural and environmental drivers. The authors estimated that 1 in 9 US adults currently takes a glucagon-like peptide-1 receptor agonist and said obesity prevalence may be declining for the first time in decades, while severe obesity continues to rise. They said the insurance system discourages treatment through noncoverage and onerous prior authorizations, and they called for coverage of lifestyle, medical, and surgical care, stronger regulation of compounded drugs, food policy action, and stigma-free care environments. The report suggested expanding the Medicare GLP-1 Bridge and the Medicaid BALANCE initiative if they prove successful.

Source: www.ajmc.com

About Us

Toolq Media Is a Global News Platform Covering the Latest Developments and Breaking Stories from Around The World, Including World News, Business, Finance, Technology, Health, Politics, Science, Entertainment, Sports, and More.

Toolq

Toolq @2026. All Rights Reserved.